RCT of ACP for Transplant

Study Overview
=================
Brief Summary
-----------------
We aim to examine the effect of an online advance directive on decisional conflict and quality of life in patients undergoing stem cell transplant. We also aim to assess the effect of palliative care at the time of a sentinel event on quality of life.

Official Title
-----------------
A Pilot Randomized Control Trial of Advance Care Planning and Triggered Palliative Care for Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)

Conditions
-----------------
Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)

Intervention / Treatment
-----------------
* Other: Surveys


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The inclusion criteria for Phase I (primary objective) are as follows: Age ≥ 18 years Hematologic malignancy diagnosis including any subset of myeloma, lymphoma, leukemia, or myelodysplastic syndrome Currently scheduled for autologous or allogeneic transplant at the Hospital of the University of Pennsylvania The inclusion criteria for Phase II (secondary objective) are as follows: Age ≥ 18 years Hematologic malignancy diagnosis including any subset of lymphoma, leukemia, or myelodysplastic syndrome Received an autologous or allogeneic stem cell transplant at the Hospital of the University of Pennsylvania and experienced a sentinel event of either 1) disease relapse,2) severe (Grade III or IV) graft-versus-host disease, or 3) unplanned hospital admission with length of stay greater than 72 hours. Exclusion Criteria: The exclusion criteria for Phase I include: Inability to read and write English Not serving as the primary decision maker for their health-related decisions Having a non-hematologic malignancy reason for undergoing transplantation (e.g. aplastic anemia) The exclusion criteria for Phase II include: Not completing participation in Phase I of the study Myeloma diagnosis

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Phase 1<br> | Other: Surveys<br>* Instruments will be administered via the online RedCAP platform. The survey instruments will include a Decision Conflict Scale (DCS), the McGill Quality of Life (MQoL), the Human Connection (THC), and a general demographics questionnaire. Patients will have the opportunity to complete the instruments via a research iPad while in clinic or via a survey link emailed to their private email account.<br>|
| Phase 2<br> | Other: Surveys<br>* Instruments will be administered via the online RedCAP platform. The survey instruments will include a Decision Conflict Scale (DCS), the McGill Quality of Life (MQoL), the Human Connection (THC), and a general demographics questionnaire. Patients will have the opportunity to complete the instruments via a research iPad while in clinic or via a survey link emailed to their private email account.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of surveys completed |  | 2 years |